000 01581cam  2200337za 4500
0019.844404
003CaOODSP
00520221107152736
007cr |||||||||||
008170922s2017    oncd    o    f000 0 eng d
022 |z1925-0932
040 |aCaOODSP|beng
043 |an-cn---
0861 |aH113-25/2017-15E-PDF|zH113-25/2017-15E
24500|aSaflufenacil |h[electronic resource].
260 |aOttawa : |bHealth Canada, Pest Management Regulatory Agency, |c2017.
300 |a5 p. : |bcharts
4901 |aRegistration decision, |x1925-0940 ; |vRD2017-15
500 |aIssued also in French under title: Saflufénacil.
500 |aCover title.
500 |a"15 September 2017.”
520 |a“Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is granting full registration for the sale and use of saflufenacil technical, Kixor and the herbicide end-use product, Detail, containing the technical grade active ingredient saflufenacil, to control broadleaf weeds in non-cropland areas"--P. 1.
530 |aIssued also in print format.
69207|2gccst|aHerbicides
69207|2gccst|aCertification
69207|2gccst|aToxicology
7101 |aCanada. |bHealth Canada.
7101 |aCanada. |bPest Management Regulatory Agency.
77508|tSaflufénacil |w(CaOODSP)9.844405
830#0|aRegistration decision,|x1925-0940 ; |vRD2017-15|w(CaOODSP)9.505184
85640|qPDF|s220 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-25/H113-25-2017-15-eng.pdf